The company announced that the Canadian Medical service Administrative bureau authorizes the ERBITUX merge radiotherapy, partial treatment initial period pate tumor.

• 公司并宣布，加拿大医疗管理局批准ERBITUX合并放射疗法，局部治疗初期头颈部肿瘤。